CIPLANSECipla Limited· PharmaceuticalsMediumNeutral
Announced Sun, 1 Jun · 19:15 IST

Cipla Limited has informed the Exchange about appointment of Mr Prabhakaran Balakrishnan Nair as Senior Management Personnel and Global Chief Manufacturing Officer of the Company w.e.f. 1st July, 2025.

Management Changes View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Cipla Limited has appointed Mr Prabhakaran Balakrishnan Nair as Senior Management Personnel and Global Chief Manufacturing Officer, effective 1st July 2025. He has been promoted internally from his current role as Chief of Quality at Cipla's Indore plant, where he is also a member of the Cipla Leadership Group. He brings over 34 years of experience in pharmaceutical manufacturing and quality, having previously served as COO at Encube Ethicals and held senior roles at Dr. Reddy's, ACG Worldwide, IPCA Laboratories, and Cadila Pharmaceuticals. He holds an MBA and M.Pharm from Mumbai University. The appointment is on a full-time employment basis.

Likely market impact

This is a routine internal senior management promotion that signals continuity in Cipla's manufacturing and quality operations. It is unlikely to have any meaningful impact on the stock price, as no KMP, CEO, or CFO-level change is involved.